Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: specified in variables

;Total;Units;P.A.;Higher Education;PNPI;
Units that perform R+D in Biotechnology;1.273;1.078;126;59;10;
%Units according to biotechnology used: Genetic code;43;35;91;93;60;
%Units according to biotechnology used: Functional units;49;42;89;98;60;
%Units according to biotechnology used: Cellular and tissue culturing and engineering;34;27;68;90;70;
%Units according to biotechnology used: Bioprocesses;51;49;55;92;30;
%Units according to biotechnology used: Sub-cellular organisms;16;8;54;73;40;
%Units according to biotechnology used: Bio-computing;30;22;70;85;20;
%Units according to biotechnology used: Nanobiotechnology;19;14;38;76;10;
%Units according to biotechnology used: Other;12;12;11;12;10;
Units in which biotechnology activities are:  Main and/or exclusive;575;526;37;3;9;
Units in which biotechnology activities are: A secondary line of business;249;173;37;39;.;
Units in which biotechnology activities are: A tool necessary for production;449;379;52;17;1;
%Units by field(s) of ultimate application of biotechnology use: Human health;54;48;79;95;80;
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;21;20;16;56;10;
%Units by field(s) of ultimate application of biotechnology use: Food products;34;33;22;78;10;
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;26;24;20;68;30;
%Units by field(s) of ultimate application of biotechnology use: Environment;18;15;21;71;.;
%Units by field(s) of ultimate application of biotechnology use: Industry;16;14;13;75;.;
Personnel in R&D in biotechnology (no. of persons);35.523;10.191;12.545;12.512;275;
Personnel in R&D in biotechnology (no. of persons): Researchers;22.884;5.774;7.135;9.744;231;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;12.639;4.417;5.410;2.768;44;
Personnel in R&D in biotechnology (no. of persons): women;19.474;5.525;7.462;6.323;164;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;11.830;3.015;3.974;4.705;136;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;7.645;2.511;3.488;1.618;28;
Personnel in R&D in biotechnology (FTE);24.279,7;7.191,4;9.631,4;7.374,2;82,7;
Personnel in R&D in biotechnology (FTE): Researchers;15.072,1;4.276,6;5.063,5;5.675,1;56,9;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;9.207,5;2.914,7;4.567,9;1.699,1;25,8;
Personnel in R&D in biotechnology (FTE): women;13.704,2;3.985,4;5.788,9;3.875,9;54;
Personnel in R&D in biotechnology (FTE): (women) Researchers;8.019,5;2.234;2.874,7;2.873,9;36,9;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;5.684,7;1.751,4;2.914,2;1.002;17,1;
Internal expenditure on R&D (thousands of euros);1.540.444;578.171;578.663;378.946;4.664;
1) By nature of the expense: Current expenses;1.394.144;517.601;535.547;336.445;4.552;
1.1) Remuneration to researchers;621.703;213.755;196.017;210.289;1.642;
1.2) Remuneration to technicians and assistants;272.048;98.440;127.585;45.267;757;
1.3) Other current expenses;500.394;205.406;211.946;80.890;2.153;
2) By nature of the expense: Capital expenses;146.299;60.570;43.117;42.501;111;
2.1) Land and buildings;38.481;22.609;4.286;11.587;.;
2.2) Equipment and instruments;103.079;36.169;37.163;29.636;111;
2.3) Acquisition of specific R+D software;4.739;1.793;1.668;1.278;.;
1) By origin of the funds: National funds;1.367.285;487.615;535.786;339.305;4.579;
1.1) Own funds;475.645;330.459;78.574;65.797;815;
1.2) From companies;131.856;45.462;53.216;31.579;1.600;
1.3) Public Administration funds;687.638;66.189;385.359;234.788;1.302;
1.4) From Universities;28.830;25.148;3.221;423;38;
1.5) From non profit private institutions;43.316;20.357;15.416;6.719;825;
1) By origin of the funds: Foreign funds;173.159;90.556;42.878;39.640;84;
2.1) From EU programmes;91.809;20.932;36.730;34.147;.;
2.2) Other foreign funds;81.350;69.624;6.148;5.494;84;
Purchase of services R & D in Biotechnology to (thousands of euros);197.452;166.022;30.859;569;2;
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;125.047;97.455;27.061;530;1;
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;72.404;68.567;3.799;39;.;
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;48;46;60;58;60;
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;13;13;11;12;10;
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;18;14;41;42;10;
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;16;14;28;31;10;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;20;17;34;44;30;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;20;17;34;39;40;
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;18;18;14;15;20;
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;35;35;38;27;10;
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;49;49;47;61;50;
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;20;21;20;12;10;
%Units that have requested biotechnology patents in Biotechnology;22;15;51;75;.;
Number of patents requested;1.877;526;756;595;.;
Notas:

.
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute